Ignite Creation Date:
2024-05-06 @ 3:29 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04645953
Status:
COMPLETED
Last Update Posted:
2022-09-27
First Post:
2020-11-16
Brief Title:
Staccato Granisetron AZ 010 for the Treatment of Cyclic Vomiting Syndrome
Sponsor:
Alexza Pharmaceuticals Inc
Organization:
Alexza Pharmaceuticals Inc
Study Overview
Official Title:
A Randomized Double-Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of Staccato Granisetron AZ-010 for the Acute Treatment of Moderate to Severe Cyclic Vomiting Syndrome
Status:
COMPLETED
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter randomized double-blind parallel group placebo-controlled efficacy and safety study of adult outpatients diagnosed with CVS and experiencing recurring episodes of stereotypical vomiting
Detailed Description:
A Randomized Double-Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of Staccato Granisetron AZ-010 for the Acute Treatment of Moderate to Severe Cyclic Vomiting Syndrome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None